[1] LIU DT, SI TM, ZHENG Y, et al.Expert Recommendations for the Clinical Application of Aripiprazole[J]. Journal of Clinical Psychiatry(临床精神医学杂志), 2021, 31(5): 337-341. [2] YU X, FANG YR.Guidelines for the Prevention and Treatment of Bipolar Disorder in China (Second Edition) (中国双相障碍防治指南第二版)[M]. Beijing: Chinese Medical Electronic Audiovisual Press, 2015: 74-85. [3] FOUNTOULAKIS KN, GRUNZE H, VIETA E, et al.The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines[J]. Int J Neuropsychopharmacol, 2017, 20(2): 180-195. [4] YATHAM LN, KENNEDY SH, PARIKH SV, et al.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 Guidelines for the Management of Patients with Bipolar Disorder[J]. Bipolar Disord, 2018, 20(2): 97-170. [5] Guidelines for the Treatment of Acne in China (RevisedEdition 2019)(中国痤疮治疗指南 2019修订版)[J]. Journal of Clinical Dermatology, 2019, 48(9): 583-588. [6] BAI S, ZHANG YP, LI H, et al.Clinical Analysis of 73 Patients with Rosacea[J]. Chinese Journal of Laboratory Diagnosis(中国实验诊断学), 2021, 25(9): 1374-1375. [7] ZHANG H, WANG M, ZHAO X, et al.Role of Stress in Skin Diseases: a Neuroendocrine-Immune Interaction View[J]. Brain Behav Immun, 2024, 116: 286-302. [8] GUO Q, REN H, ZHONG TT, et al.Mental Health Status and Influencing Factors of Patients with Moderate to Severe Acne[J]. Sichuan Mental Health(四川精神卫生), 2024, 37(4): 335-340. [9] SAMUELS DV, ROSENTHAL R, LIN R, et al.Acne Vulgaris and Risk of Depression and Anxiety: a Meta-Analytic Review[J]. J Am Acad Dermatol, 2020, 83(2): 532-541. [10] GAO J, XU N.The Whole Process Management of Acne Vulgaris[J]. Dermatology Bulletin(皮肤病学通报),2024, 41(1): 93-99. [11] PARK HE, KIM YH, LEE JH.Dose-Related Aripiprazole-Induced Acneiform Eruption[J]. Ann Dermatol, 2023, 35(Suppl 1): 168-169. [12] MISHRA B, PRAHARAJ SK, PRAKASH R, et al.Aripiprazole-Induced Acneiform Eruption[J]. Gen Hosp Psychiatry, 2008, 30(5): 479-481. [13] ALENZI KA, ALANAZI NS, ALMALKI M, et al.The Evaluation of Adverse Drug Reactions in Saudi Arabia: a Retrospective Observational Study[J]. Saudi Pharm J, 2022, 30(6): 735-741. [14] www.gov.cn. Measures for the Reporting and Monitoring of Adverse Drug Reactions[EB/OL]. (2011-05-04)[2024-11-21]. https://www.gov.cn/zhengce/2011-05/24/content_2603398.htm. [15] JU Q, LI JQ.Re-Understanding of Acne Vulgaris: from Pathogenesis to Treatment Strategies[J]. Chinese Journal of Dermatology(中华皮肤科杂志), 2024, 57(4): 289-294. [16] NAVARRO-TRIVIÑO FJ, DE JAIME RUIZ P, PORRAS SEGOVIA A, et al. Oral Isotretinoin for the Treatment of Aripiprazol-Induced Acneiform Rash[J]. Dermatologic Therapy, 2018, 31(4): e12637. [17] HUANG L, YANG S, YU X, et al.Association of Different Cell Types and Inflammation in Early Acne Vulgaris[J]. Front Immunol, 2024, 15: 1275269. [18] LI Y, QU FL, WANG L, et al.Study on the Influencing Factors of the Ratio of Serum Drug Concentration to Dose of Aripiprazole[J]. Chinese Pharmacist(中国药师), 2022, 25(3): 455-457. [19] JIA RC, LIN JR.The Role of Androgens in the Pathogenesis and Therapeutic Application of Acne[J]. The Chinese Journal of Derma-tovenereology(中国皮肤性病学杂志), 2023, 37(5): 503-508. [20] READ J, SACIA A.Using Open Questions to Understand 650 People's Experiences with Antipsychotic Drugs[J]. Schizophr Bull, 2020, 46(4): 896-904. |